- Global Pharma News & Resources

Press Releases - 2019-11-05

Date Title Company
05-Nov-2019 Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results Jazz Pharmaceuticals plc
05-Nov-2019 Theravance Biopharma, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update Theravance Biopharma, Inc.
05-Nov-2019 Provention Bio Reports Third Quarter 2019 Financial Results Provention Bio, Inc.
05-Nov-2019 Rigel Announces Third Quarter 2019 Financial Results Rigel Pharmaceuticals, Inc.
05-Nov-2019 Portola Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update Portola Pharmaceuticals, Inc.®
05-Nov-2019 New EU mandate can provide relief for Europe’s most productivity-destroying disease Societal Impact of Pain
05-Nov-2019 FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations U.S. Food and Drug Administration
05-Nov-2019 Study shows routine use of Artificial Intelligence-based machine learning algorithms could help dramatically increase detection rates of people with undiagnosed atrial fibrillation Bristol-Myers Squibb
05-Nov-2019 Masters Speciality Pharma Announces Launch of Neuropad® in Brazil for Detection of Diabetic Foot Syndrome Masters Speciality Pharma
05-Nov-2019 OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer Orion Biotechnology Canada
05-Nov-2019 SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announced & Brochure Released SMi Group
05-Nov-2019 PureTech Announces Presentation of New Data Supporting Wholly Owned Immuno-Oncology Programmes LYT-200 (anti-galectin-9) and LYT-210 (anti-delta-1) PureTech Health plc
05-Nov-2019 Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector Kayentis
05-Nov-2019 Polycystic Ovary Syndrome Treatment Market to Expand on Account of Rising Awareness among Women by a CAGR of 5% during 2019-2027 Research Nester
05-Nov-2019 MediClin: Group sales plus 4 % compared to previous year's period MediClin AG
05-Nov-2019 Mallinckrodt plc Announces Exchange Offers and Consent Solicitations Mallinckrodt plc
05-Nov-2019 ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer ADC Therapeutics SA
05-Nov-2019 Mallinckrodt plc Reports Earnings and Pipeline Advancements for the Third Quarter 2019 and Raises Adjusted Diluted Earnings Per Share Guidance Range for 2019 Mallinckrodt plc
05-Nov-2019 IDEAYA Biosciences Announces Leadership Updates in Research Organization IDEAYA Biosciences, Inc.